Form 4 for DGX Quest Diagnostics
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001022079-24-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-27 | 2024-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $125.02 | -6,525 | 131.0K | -5% | -$815.8K | |
| 2024-02-27 | 2024-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $125.02 | +13.4K | 137.5K | +11% | +$1.67M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | F | D | 6,525 | $125.02 | 130,988 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-23 | A | A | 13,390 | $125.02 | 137,513 | D | — | — |